For S’pore stock market to develop, Catalist investors should be prepared to accept more risk

Sponsors are qualified professional companies experienced in corporate finance and compliance advisory work, and are authorised and regulated by the SGX.

Catalist was formed to encourage younger, fast-growing companies to list and gain access to funding, and has fewer requirements than the mainboard.

PHOTO: ST FILE

Kang Wan Chern

Follow topic:

SINGAPORE – Cancer-treatment provider Singapore Institute of Advanced Medicine (Siam) has been busy

replying to a slew of questions from worried shareholders

and the bourse regulator after its auditor raised doubts over the company’s ability to continue operating.

The Dec 9 audit report also sparked debate about whether Siam had gone public on Catalist before it was ready, and if more should have been done by the company, its sponsor PrimePartners Corporate Finance and Singapore Exchange Regulation (SGX RegCo) to warn investors about the uncertainties of the business and its poor financial health.

For S’pore stock market to develop, Catalist investors should be prepared to accept more risk

Follow topic:

See more on